Anti-blood stasis syndrome application of scirpusin A component in Rhizoma Sparganii
A technology of blood stasis syndrome and triangular element, applied in the field of medicine, can solve the problem that the effective ingredients of triangular prism are not clear enough and so on.
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0026] Example 1 compound blood circulation promoting function experiment
[0027] 1. Experimental materials
[0028] (1) Drugs: Trilens A, Trisensin B and Trisensin C were self-made in the experiment, with a purity of ≥99%.
[0029] (2) Animal: KM mouse, ♀, body weight 25±5g, provided by Guangdong Experimental Animal Center, license number: SCK (Guangdong) 2013-0002.
[0030] (3) Reagents
[0031] Epinephrine Hydrochloride Injection (Grand Medicine (China) Co., Ltd., batch number: 20170214); Bayer Aspirin Enteric-Coated Tablets (Bayer Healthcare Co., Ltd., batch number: BJ32400); Carboxymethylcellulose Sodium (CMC-Na, Sinopharm Chemicals Reagent Co., Ltd., batch number: F20110915, analytically pure); sodium chloride (Tianjin Zhiyuan Chemical Reagent Co., Ltd., batch number: 20160312, analytically pure); mouse thromboxane B2 (TXB2), endothelin 1 (ET-1), Plasminogen activator inhibitor 1 (PAI-1), fibrinogen (FIB) enzyme-linked immunoassay kit (Tianjin Anoricang Biotechnology...
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com